Company / Gross Profit per Share
Vericel Gross Profit per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit per Share
$4.14
FY2025
5-year range
$1.75 / $4.14
FY2021-FY2025
Trend
+15.1%
vs FY2024
Sector context
#18 of 29
Health Care
What the data says
At $4.14, Vericel's gross profit per share ranks #18 of 29 in the Health Care sector. Gross Profit per Share has increased for 7 consecutive years, from $0.73 in FY2018 to $4.14 in FY2025.
Based on SEC 10-K filings.
4.14 in FY2025 with a 5-year CAGR of +25.9%.
Improved from $2.87 to $4.14 over the past 2 years.
Health Care sector context is included.
Gross Profit per Share over time
Growth rates
- 3-Year CAGR
- +32.1%
- 5-Year CAGR
- +25.9%
- 10-Year CAGR
- -
Sector benchmark
#18 of 29 in Health CareTop 62% of 29This company $4.14 Sector average $8.10
▼
-48.9% below sector average
Key checks
Key Insights
- Vericel's gross profit per share has grown for 7 consecutive years.
- In FY2025, gross profit per share increased 15.1% year-over-year.
- Ranks #18 out of 29 companies in the Health Care sector.
- Lowest gross profit per share in the period was in FY2016.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross Profit per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.14 | +15.1% |
| FY2024 | $3.60 | +25.4% |
| FY2023 | $2.87 | +59.7% |
| FY2022 | $1.80 | +2.5% |
| FY2021 | $1.75 | +34.0% |
| FY2020 | $1.31 | +69.8% |
| FY2019 | $0.77 | +5.9% |
| FY2018 | $0.73 | -7.0% |
| FY2017 | $0.78 | +61.7% |
| FY2016 | $0.48 | +76577.0% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026